Wall Street giant Morgan Stanley promoted 173 of its employees to managing director roles this year, marking a 12% increase ...

Morgan Stanley (MS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

A good investment trust can act as a solid anchor for a Stocks and Shares ISA, helping investors maintain steady long-term ...

Morgan Stanley is a buy on weakness with strong dividend growth and projected revenue growth in Q4 2024 and early 2025. Click for our MS earnings preview.

JP Morgan analyst Kian Abouhossein maintained a Neutral rating and boosted the price target from $100 to $104 on Dec. 6, 2024 ...

Morgan Stanley expects improving freight conditions and upcoming emissions regulations to boost global truck manufacturers in 2025, with Daimler (OTC:MBGAF) Truck Holding AG (F:DTGGe) and Volvo ...

Vir Biotechnology (VIR) stock was upgraded by Morgan Stanley after the company posted trial data for two antitumor agents ...

Morgan Stanley (NYSE:MS) analysts have upgraded Vir Biotechnology (NASDAQ:VIR) to an "overweight" rating, shifting from ...

Investing.com - Experian's (LON:EXPN) outlook for margin expansion is "robust" and underpins the potential for sustained ...

Morgan Stanley Investment Management (MSIM) announced today that the 1GT private climate equity strategy (1GT) participated in a ?115 million fundraise for XOCEAN (company), a leading provider of ...

Global equity issuance rose 20% last year, but stock market launches have so far lagged that increase, remaining far below ...

Andrew Forrest has taken a ‘bring it on’ stance in response to ExxonMobil’s defamation lawsuit, which it has filed against ...